Cash Flow Statement

Acquisitions Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Amrize (AMRZ) Capital Expenditures (2024 - 2025)

Amrize (AMRZ) has disclosed Capital Expenditures for 2 consecutive years, with $157.0 million as the latest value for Q4 2025.

Quarterly Capital Expenditures rose 86.9% to $157.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $647.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $788.0 million for FY2025, 22.74% up from the prior year.
Capital Expenditures hit $157.0 million in Q4 2025 for Amrize, down from $185.0 million in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $221.0 million in Q3 2024 to a low of $84.0 million in Q4 2024.